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Professor Jean-Martin Charcot (Charcot), the brilliant
French neurologist considered the father of modern neu-
rology and the first professor of diseases of the nervous sys-
tem, is regarded as one of the most important researchers
in the field of clinical neurology in the 19th century (Fig-
ure 1).1–3
Using his famous anatomo-clinical method, Charcot
described a range of neurological diseases, some of which
bear his name.
Charcot’s masterly contributions to neurology are ex-
ceedingly well-known, particularly those related to multi-
ple sclerosis (or sclerosis in plaques according to Charcot’s
original definition), lateral amyotrophic sclerosis (or Char-
cot’s disease), Charcot-Marie-Tooth disease (or hereditary
motor and sensory neuropathy, according to the current
definition), motor ataxia, Parkinson’s disease, and Gilles
de la Tourette syndrome, among other diseases.1–8
Charcot’s contributions in different areas of internal
medicine have been reviewed by several authors over the
past few years.9–15
However, other important contributions by Charcot are
little remembered today, and this led us to undertake this
short review of these contributions in different areas of in-
ternal medicine as well as in pathological anatomy, neu-
rology, and psychiatry.
Little-Known Scientific Contributions of Charcot in
Neurology and Psychiatry:
Some of the countless important contributions Charcot
made in the field of neurology are little known and not
widely published, possibly eclipsed by the magnitude of
his other world-famous contributions. Along with his pu-
pil, the pathologist Charles Joseph Bouchard, Charcot de-
scribed the Charcot-Bouchard microaneurysms, still recog-
nized as one of the main causes of primary intracerebral
hemorrhages. Some of the little-known diseases described
by Charcot include the disease known as Charcot’s oph-
thalmoplegic migraine (paralysis of the Oculomotor Nerve
in patients with classic migraine)16,17; Charcot-Joffroy syn-
drome, a rare form of cervical myelopathy known as idi-
opathic hypertrophic cervical pachymeningitis; and Erb-
Charcot paralysis (spinal syphilis with sensory deficits,
spastic paresis, and amyotrophy). He published a number
of papers related to aphasia (he created a diagram of the
sinus in which he explained the circuits involved in the
speech process)1 and visual agnosia1,7,12,13 among other con-
tributions. There are several other diseases described by
Figure 1 - J-M Charcot (1825-1893) (Extracted from http://
webperso.easyconnect.frlbaillment/images/charcot.gif).
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Charcot and his colleagues, such as Charcot-Wilbrand syn-
drome and Souques-Charcot syndrome.12
Charcot’s first studies regarding to decubitus ulcers are
particularly noteworthy, because they are very common in
bedridden patients suffering from neurological lesions. He
believed that decubitus ulcers were caused by the loss of
neurotrophic factors and suggested that their appearance
could be a sign of bad prognosis, indicating that the pa-
tient would soon die. He called these lesions “decubitus
ominosus.”18,19 He also stated that decubitus ulcers would
rarely be found, or would be absent, in amyotrophic lat-
eral sclerosis.7,19,20
According to current medical terminology, in the last
phase of his brilliant career, Charcot would be considered
a psychiatrist.21–23 His contributions to this field are very
relevant, particularly those related to hysteria. His work in
this area, including his studies of hypnosis, made him world
famous, and his Salpêtrière Neurological Service took the
lead in the field.1
His studies of the diseases known as somatoform dis-
orders and his attempts to better catalog them and bring
them out of the scientific obscurity which surrounded them
at the time were remarkable. Another of Charcot’s contri-
butions in the intersection with psychiatry was related to
studies into obsessive-compulsive disorder (which he called
“idée fixe”), particularly in patients with tics or Tourette’s
syndrome.1–3,21–23
Little-Known Scientific Contributions of Charcot in
Internal Medicine:
Charcot’s scientific contributions in different areas of
internal medicine, and subsequently in neurology, reflect
the renowned researcher’s increasing involvement in clini-
cal medicine in his earlier years, more specifically in neu-
rology following the creation of the chair in Diseases of
the Nervous System in 1883 in the Faculty of Medicine at
the University of Paris.1–3,7
His inaugural thesis, defended at the Faculty of Medi-
cine at the University of Paris in 1853, was a classical de-
scription of progressive chronic rheumatism, differentiat-
ing it from cases of gout.3 The title of Charcot’s thesis was
“Étude pour servir à l´histoire de l´affection décrite sous
le nom de goute asthénique primitive, nodosités des join-
tures, rhumatisme articulaire chronique (forme primitive).”3
In 1863, with his student Cornil, Charcot studied anatomi-
cal lesions of the joints and kidneys in patients diagnosed with
gout and investigated the possibility of a connection with lead
poisoning.3 Even without having established a correlation with
uric acid levels, Charcot investigated the effectiveness of col-
chicine in the treatment of gout.1,8
The lesion known as Charcot’s joint, which was actu-
ally an arthropathy described in patients with tabes dorsa-
lis (neurosyphilis) or progressive motor ataxia, began to be
defined as a result of studies that Charcot started in 1868,
and the disease became known worldwide as an arthropa-
thy associated with motor ataxia during the 7th International
Medical Congress held in London in 1881.3 In 1883, Char-
cot and Fere published a study about the tabetic foot (“Pied
Tabétique”).3
Another articular disease described by Charcot is related
to the well-known diabetic foot disease. Many patients with
diabetic foot actually present an arthropathy known as Char-
cot’s arthropathy, which is a progressive degenerative arthropa-
thy associated with various kinds of neuropathic diseases but
which is undoubtedly much more common in patients with
diabetes mellitus,9 as determined by Jordan as late as 1936.10
This arthropathy predominantly affects the feet, leading to
structural deformities and the risk of developing ulcers on the
feet and even osteomyelitis. This clinical picture has become
known world wide as diabetic Charcot’s foot.9–11
Charcot also studied exophthalmic goiter, a disease pre-
viously described by Basedow in Germany and Granes in
England.3 He described an improvement in the clinical find-
ings in pregnant patients and also described the presence
of different sorts of tremors in the disease, inspiring his co-
worker Pierre Marie to write a thesis on Basedow’s disease.3
Another of Charcot’s contributions, previously studied
by Von Zencker in 1851, was to define the crystals known
as Charcot-Leyden or Charcot-Robin crystals found in pa-
tients with asthma. These crystals are actually phosphate
crystals and are found in the sputum of patients with bron-
chial asthma and also in the feces of patients with ulcera-
tive colitis. Similarly, Charcot-Neumann crystals, which
also contain phosphate crystals were described in semen.12,13
Charcot also described what is known as the biliary triad
or Charcot’s triad. The triad is characterized by the pres-
ence of recurring abdominal pain in the upper right quad-
rant associated with fluctuating jaundice and intermittent
fever with shivers and is associated with the presence of
acute cholangitis caused by choledocholithiasis.11,14
Intermittent claudication of arterial origin, also known
as Charcot’s angina cruris, was originally described by
Charcot.12,13 It is characterized by the presence of pain, dis-
comfort, weakness, or leg cramps. These are most common
after physical exercise or walks and disappear after rest.
The disorder is the result of arterial obstruction of the ter-
minal aorta and iliac arteries, causing reduced circulation
in the leg muscles.12 Charcot described this disease in de-
tail in a soldier who had been injured by a firearm and who
developed an aneurysm that formed a thrombus blocking
the iliac arteries. He based his study on the description,
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published in an article in 1831 by the Parisian veterinary
surgeon, Jean-François Bouley, of claudication in a horse
that pulled a carriage through the streets of Paris and had
difficulty using its hind feet whenever it had to exercise
more stenuously. The animal presented thrombi obstruct-
ing the femoral arteries.12,15,24,25 Another contribution related
to the field is Charcot’s edema, a painful and bluish edema
described in women with hysterical paralysis.1,7
In the field of medicine known today as
neurocardiology, Charcot gave a detailed description of vas-
ovagal syncope, which is characterized by transitory attacks
of significantly reduced heartbeat, reduced arterial pressure,
and loss of consciousness.12,13 He also described the type
of syncope triggered by coughing (called Charcot’s vertigo
or cough syncope, in which the fit of coughing provokes a
spasm of the glottis followed by vertigo and then syncope)
as well as syncope triggered by compression of the carotid
sinus (carotid sinus hypersensitivity syndrome). In the lat-
ter condition, initially described by J.N. Czermak in 1866
and also known as the Charcot-Weiss-Baker syndrome, the
attacks of syncope, which are transitory and associated with
bradycardia and arterial hypotension, are related to the ap-
plication of pressure on the neck at the location of the fork
in the common carotid artery, or even to sudden rotation
of the neck or the use of a tight collar.12,13
Charcot can also be considered to have pioneered the
study of diseases of the elderly, although his contributions
in the fields of geriatrics and gerontology are not well
known.26,27 He was one of the pioneers in setting up reha-
bilitation clinics with physiotherapy, speech therapy, hy-
drotherapy, and electrical stimulation of paralyzed muscles,
and he also recommended treatment with electrostatic baths
supplemented with sulfur salts in thermal springs or spas.1,8
Lastly, one cannot forget that Charcot described a large
number of diseases in different areas of internal medicine
including neurology and psychiatry, causing Lellouch to
define him as the “discoverer of diseases.”28 Charcot made
use of the well-known anatomo-clinical method and thus
also became recognized as an important anatomo-patholo-
gist.29
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